Fifth disease

Last updated
Erythema infectiosum
Other namesFifth disease, Slapped cheek syndrome, slapcheek, slap face, slapped face [1] [2]
Fifth disease.jpg
16-month-old with erythema infectiosum, displaying characteristic red rashes
Specialty Infectious disease
Symptoms Red rash, especially on cheeks and harsh coughs
CausesHuman parvovirus

Erythema infectiosum, fifth disease, or slapped cheek syndrome [3] is one of several possible manifestations of infection by parvovirus B19. [4] Fifth disease typically presents as a rash and is more common in children. While parvovirus B19 can affect humans of all ages, only two out of ten individuals will present with physical symptoms. [5]

Contents

The name "fifth disease" comes from its place on the standard list of rash-causing childhood diseases, which also includes measles (first), scarlet fever (second), rubella (third), Dukes' disease (fourth, but is no longer widely accepted as distinct from scarlet fever), and roseola (sixth). [6] Treatment is mostly supportive.

Signs and symptoms

Fifth disease starts with a low-grade fever, headache, rash, and cold-like symptoms, such as a runny or stuffy nose. [7] These symptoms pass, then a few days later, the rash appears. The bright red rash most commonly appears in the face, particularly the cheeks. [7] This is a defining symptom of the infection in children (hence the name "slapped cheek disease"). [7] Occasionally, the rash will extend over the bridge of the nose or around the mouth. In addition to red cheeks, children often develop a red, lacy rash on the rest of the body, with the upper arms, torso, and legs being the most common locations. The rash typically lasts a few days and may itch; some cases have been known to last for several weeks. Patients are usually no longer infectious once the rash has appeared. [1] [2]

Teenagers and adults may present with a self-limited arthritis. [7] It manifests in painful swelling of the joints that feels similar to arthritis. Older children and adults with fifth disease may have difficulty in walking and in bending joints such as wrists, knees, ankles, fingers, and shoulders. [1] [2]

The disease is usually mild, [8] but in certain risk groups and rare circumstances, it can have serious consequences:

Causes

Fifth disease, also known as erythema infectiosum, is caused by parvovirus B19, which only infects humans. [11] Infection by parvovirus B19 can lead to multiple clinical manifestations, but the most common is fifth disease. [12]

Parvovirus B19 (B19V) is a small, single-stranded, non-enveloped DNA virus. Binding of B19V capsid to the cellular receptor globoside (Gb4Cer) results in a cascade of structural changes and subsequent signal transduction processes facilitating the entry of parvovirus B19 into the host cell. After gaining access to the host cell, B19V binds to glycosphingolipid globoside (blood group P antigen) targeting erythroid lineage in the bone marrow. Replication of viral genome and release of virus from infected cells lead to various complex effects on host's cellular environment such as induction of DNA damage, hijack of cell cycle and apoptosis (killing of infected cells). [13] [14]

B19V DNA has been found in a wide range of tissues in healthy and diseased individuals indicates the persistence of B19V infection. According to a clinical microbiology review published by Jianming Qiu "Persistence of viral DNA has been detected in up to 50% of biopsy specimens of the spleen, lymph nodes, tonsils, liver, heart, synovial tissues, skin, brain, and testes, for decades after infection." [15]

Recovery from parvovirus B19 infection is achieved by production of IgM antibodies which are specific for virus and are generated 10–12 days after infection. [14] After day 16, when signs of fifth disease (red rashes) and arthralgia (pain in joints) becomes apparent, specific anti B19 IgG is produced by immune cells. Production of serum anti B19 IgG keeps infection under control and facilitates the recovery of erythroid cell production in erythroid lineage cells that were targeted by parvovirus B19. [16]

Diagnosis

The "slapped cheek" appearance of the rash can be suggestive of fifth disease, however, the rash can be mistaken with other skin related disease or infections. Blood samples testing can be definitive in confirming diagnosis. [11] Anti-parvovirus B19 IgM antibody serum assay is the preferred method to detect previous infection. An antibody assay uses antibodies designed to detect parvovirus antigen or protein in blood circulation. The assay can result positive one week after initial infection. Negative results may prompt retesting in the future to rule out early sampling of blood serum. [17] A positive result can also be indicative of an infection within the past two to six months. [11] People acquire lifetime immunity if IgG antibodies are produced in response to parvovirus B19 exposure. [18] Infection by parvovirus B19 can also be confirmed by isolation of viral DNA detected by PCR or direct hybridization. PCR Is considered significantly more sensitive to detecting viral antigen compared direct DNA hybridization. DNA hybridization assay can better detect variants of the parvovirus B19. [19] There exists 3 biological similar genotypes of parvovirus B19, numbered one through three. The most common genotype circulating is genotype one. [15] Laboratory tests can indicate complications of infection, including anemia, liver damage, and low platelet count. [17]

Transmission

Fifth disease is transmitted primarily by respiratory secretions (saliva, mucus, etc.), but can also be spread by contact with infected blood. The incubation period (the time between the initial infection and the onset of symptoms) is usually between 4 and 21 days. Individuals with fifth disease are most infectious before the onset of symptoms. Typically, school children, day-care workers, teachers, and parents are most likely to be exposed to the virus. When symptoms are evident, the risk of transmission is small; therefore, symptomatic individuals do not need to be isolated. [1] [2] Vertical transmission from maternal infection may also occur, which can lead to hydrops fetalis due to the infection's detrimental effects on red blood cell production. [18]

Treatment

Treatment is supportive, as the infection is frequently self-limiting. No specific therapy is recommended. Antipyretics are commonly used to reduce fevers. In cases of arthropathy, such as those with arthritis or arthralgia, non-steroidal anti-inflammatories (NSAIDs) or other anti-inflammatories can be used. [11] The rash usually does not itch, but can be mildly painful. The rash itself is not considered contagious. [20] The infection generally lasts about 5 to 10 days. Stress, hot temperatures, exercise, and exposure to sunlight can contribute to reoccurrence within months of the initial infection. Upon resolution, immunity is considered life-long. [21] Populations at greater risk of complications (see below) may need referral to a specialist. Anemia is a more severe complication that could result from parvovirus B19 infection and requires a blood transfusion as part of therapy. [13]

Epidemiology

Fifth disease is a viral illness caused by Parvovirus B19. The illness is very common and self-limiting. The modes of transmission include respiratory droplets, blood, or mother to fetus. [22] As with all respiratory pathogens once presumed to transmit via respiratory droplets, it is highly likely to be carried by the aerosols generated during routine breathing, talking, and even singing. [23] Fifth Disease is most prevalent in children aged 5 to 15 years old. Fifth disease occurs at lower rates in adults. [24] The virus spreads easily and once contracted, the body will begin developing lasting immunity to reinfection. The prevalence of antibodies is 50% in children and 70% to 85% in adults. [22] The virus affects both men and women equally. [25] During the spring and winter, epidemic outbreaks are most likely to occur. In the summer and fall, sporadic cases and outbreaks occur. [26] The outbreaks most commonly occur in daycares and schools. [27] The periodicity of the outbreak cycle is three-to-seven years. [26] The risk of acquiring the viral illness increases when exposed to an infected person or contaminated blood. Individuals who have an occupation that requires close contact with infected people such as healthcare workers and teachers are at an increased risk of acquiring the viral illness. [28] Another risk factor of fifth disease are immunocompromised individuals, those with anemia are at a higher risk of developing complications. Pregnant women are at risk for acquiring viral illness, especially during the first half of pregnancy. Though, complications are very rare and less than 5% of these cases will experience serious complications. [29] The most common complication among pregnant women is anemia. In rare cases, severe anemia can occur, and a buildup of fluid can develop. A buildup of fluid can cause congestive heart failure or death. A blood infusion or induction may be necessary. [30] No vaccine is available for human parvovirus B19, [2] though attempts have been made to develop one. [31]

History

Parvovirus, the virus causing the fifth disease, was first discovered in 1975 by Yvonne Cossart. [32] It, or a disease presenting similarly, [33] was first described by Robert Willan in his book On Cutaneous Diseases in 1808 [34] as "rubeola, sine catarrho". It was better defined by Anton Tschamer in 1889 as a rubella variant (örtliche Rotheln) and described it as abortive rubella, identified as a distinct condition in 1896 by Theodor Escherich, and given the name erythema infectiosum in 1899. [34] [35] The term fifth disease was coined in 1905 by the Russian–French physician Léon Cheinisse (1871–1924), who proposed a numbered classification of the six most common childhood exanthems. [36] [33] [37] [38] The virus was first described in 1957 at the University of Pennsylvania by Werner et al. [39]

Vulnerable populations

A 2019 systematic review examined the rates of parvovirus B19 infection among daycare workers. Since transmission typically occurs through respiratory secretions, it was thought that daycare workers would be at an increased risk of infection because young children can spread saliva through drool. The systematic review indicates that daycare workers are at an increased risk for infection. [40] Another review also supports the finding that daycare workers have an increased risk of contracting parvovirus B19 infection. [41] A 2019 meta-analysis examined rates of parvovirus B19 infection among those with Sickle Cell Disease (SCD) using IgG and IgM antibody detection. Pooled data from Africa, Asia, and the Americas revealed a 48.8% parvovirus B19 infection prevalence among persons with SCD. Prevalence of infection was also determined by geographic location, where areas with reduced access to adequate housing had higher prevalence (Africa was 55.5%). [42] A 2020 literature review also supports the finding that persons with SCD, as well as those with the blood disorder beta thalassemia, are at a higher risk of parvovirus B19 infection. [43]

Complications

There are some known complications associated with Fifth Disease relating to pregnancy. While parvovirus B19 is typically transmitted via respiratory secretions or hand to mouth contact, it has also been known to be passed from pregnant mothers to fetuses. [44] [45] Roughly 50-75% of all pregnant women are immune to parvovirus B19 while the remainder of women are susceptible to mild illness. [10] [44] A majority of fetuses who do contract parvovirus B19 show either no significant symptoms or complete resolution of the virus. However, the following serious complications are rare but possible: miscarriage, stillbirth, fetal anemia, hepatic failure, and abnormal neurodevelopment outcome. In some cases, fetuses would develop hydrops fetalis due to congenital parvovirus B19. This condition was studied as a determinant of later fetal outcomes, such as miscarriage or perinatal death, in 2016 systematic review. The review showed that those born with parvovirus B19 that caused hydrops fetalis did have an association with higher mortality risk and higher risk of complications. [44] [46] While the potential consequences of erythema infectiosum can be quite serious in pregnancy, mothers can be tested for immunity via the presence of IgG and IgM antibodies. [8] [45]

In addition to fetuses, parvovirus B19 infection and its effects has been studied in adults as well. The virus has also been associated with the development of neurological complications, as identified in a systematic review in 2014. This analysis included a total of 89 studies covering complications in both the central and nervous system such as encephalitis, meningitis, and peripheral neuropathy. However, the specific pathophysiology of these complications has yet to be discovered but the review does encourage the use of antibody testing to determine a patient's risk. [47] Infection of this virus is not limited to the nervous system. Parvovirus B19 has also been linked to cases of cardiac inflammation that can cause structural damage to the heart over time. If the damage progresses and is significant, cardiac cell death may occur. [48]

Individuals that are living with HIV are also susceptible to complications if infected due to being immunocompromised. While relatively rare, those who live with both HIV and parvovirus B19 infection will be unable to fight off the B19 virus. This can result in substantial loss of red blood cells and cause anemia. [49]

See also

Related Research Articles

<span class="mw-page-title-main">Infectious mononucleosis</span> Common viral infectious disease

Infectious mononucleosis, also known as glandular fever, is an infection usually caused by the Epstein–Barr virus (EBV). Most people are infected by the virus as children, when the disease produces few or no symptoms. In young adults, the disease often results in fever, sore throat, enlarged lymph nodes in the neck, and fatigue. Most people recover in two to four weeks; however, feeling tired may last for months. The liver or spleen may also become swollen, and in less than one percent of cases splenic rupture may occur.

<i>Parvoviridae</i> Family of viruses

Parvoviruses are a family of animal viruses that constitute the family Parvoviridae. They have linear, single-stranded DNA (ssDNA) genomes that typically contain two genes encoding for a replication initiator protein, called NS1, and the protein the viral capsid is made of. The coding portion of the genome is flanked by telomeres at each end that form into hairpin loops that are important during replication. Parvovirus virions are small compared to most viruses, at 23–28 nanometers in diameter, and contain the genome enclosed in an icosahedral capsid that has a rugged surface.

<span class="mw-page-title-main">Rubella</span> Human viral disease

Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days. It usually starts on the face and spreads to the rest of the body. The rash is sometimes itchy and is not as bright as that of measles. Swollen lymph nodes are common and may last a few weeks. A fever, sore throat, and fatigue may also occur. Joint pain is common in adults. Complications may include bleeding problems, testicular swelling, encephalitis, and inflammation of nerves. Infection during early pregnancy may result in a miscarriage or a child born with congenital rubella syndrome (CRS). Symptoms of CRS manifest as problems with the eyes such as cataracts, deafness, as well as affecting the heart and brain. Problems are rare after the 20th week of pregnancy.

<span class="mw-page-title-main">Amniocentesis</span> Sampling of amniotic fluid done mainly to detect fetal chromosomal abnormalities

Amniocentesis is a medical procedure used primarily in the prenatal diagnosis of genetic conditions. It has other uses such as in the assessment of infection and fetal lung maturity. Prenatal diagnostic testing, which includes amniocentesis, is necessary to conclusively diagnose the majority of genetic disorders, with amniocentesis being the gold-standard procedure after 15 weeks' gestation.

Aplastic anemia (AA) is a severe hematologic condition in which the body fails to make blood cells in sufficient numbers. Aplastic anemia is associated with cancer and various cancer syndromes. Blood cells are produced in the bone marrow by stem cells that reside there. Aplastic anemia causes a deficiency of all blood cell types: red blood cells, white blood cells, and platelets.

<span class="mw-page-title-main">Roseola</span> Human disease caused by human herpesviruses

Roseola, also known as sixth disease, is an infectious disease caused by certain types of human herpes viruses. Most infections occur before the age of three. Symptoms vary from absent to the classic presentation of a fever of rapid onset followed by a rash. The fever generally lasts for three to five days, while the rash is generally pink and lasts for less than three days. Complications may include febrile seizures, with serious complications being rare.

Rh disease is a type of hemolytic disease of the fetus and newborn (HDFN). HDFN due to anti-D antibodies is the proper and currently used name for this disease as the Rh blood group system actually has more than 50 antigens and not only the D-antigen. The term "Rh Disease" is commonly used to refer to HDFN due to anti-D antibodies, and prior to the discovery of anti-Rho(D) immune globulin, it was the most common type of HDFN. The disease ranges from mild to severe, and occurs in the second or subsequent pregnancies of Rh-D negative women when the biologic father is Rh-D positive.

<span class="mw-page-title-main">Parvovirus B19</span> Human virus that infects RBC precursors

Human parvovirus B19, generally referred to as B19 virus(B19V),parvovirus B19 or sometimes erythrovirus B19, is the first known human virus in the family Parvoviridae, genus Erythroparvovirus; it measures only 23–26 nm in diameter. Human parvovirus b19 is a below-species classification of Erythroparvovirus primate1. The name is derived from Latin parvum, meaning small, reflecting the fact that B19 ranks among the smallest DNA viruses. B19 virus is most known for causing disease in the pediatric population; however, it can also affect adults. It is the classic cause of the childhood rash called fifth disease or erythema infectiosum, or "slapped cheek syndrome". The name comes from it being the fifth in a list of historical classifications of common skin rash illnesses in children.

<span class="mw-page-title-main">Hemolytic disease of the newborn</span> Fetal and neonatal alloimmune blood condition

Hemolytic disease of the newborn, also known as hemolytic disease of the fetus and newborn, HDN, HDFN, or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus at or around birth, when the IgG molecules produced by the mother pass through the placenta. Among these antibodies are some which attack antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can develop reticulocytosis and anemia. The intensity of this fetal disease ranges from mild to very severe, and fetal death from heart failure can occur. When the disease is moderate or severe, many erythroblasts are present in the fetal blood, earning these forms of the disease the name erythroblastosis fetalis.

<span class="mw-page-title-main">Hydrops fetalis</span> Human disease of fetuses

Hydrops fetalis or hydrops foetalis is a condition in the fetus characterized by an accumulation of fluid, or edema, in at least two fetal compartments. By comparison, hydrops allantois or hydrops amnion is an accumulation of excessive fluid in the allantoic or amniotic space, respectively.

<i>Carnivore protoparvovirus 1</i> Species of parvovirus

Carnivore protoparvovirus 1 is a species of parvovirus that infects carnivorans. It causes a highly contagious disease in both dogs and cats separately. The disease is generally divided into two major genogroups: FPV containing the classical feline panleukopenia virus (FPLV), and CPV-2 containing the canine parvovirus type 2 (CPV-2) which appeared in the 1970s.

<span class="mw-page-title-main">X-linked agammaglobulinemia</span> Medical condition

X-linked agammaglobulinemia (XLA) is a rare genetic disorder discovered in 1952 that affects the body's ability to fight infection. As the form of agammaglobulinemia that is X-linked, it is much more common in males. In people with XLA, the white blood cell formation process does not generate mature B cells, which manifests as a complete or near-complete lack of proteins called gamma globulins, including antibodies, in their bloodstream. B cells are part of the immune system and normally manufacture antibodies, which defend the body from infections by sustaining a humoral immunity response. Patients with untreated XLA are prone to develop serious and even fatal infections. A mutation occurs at the Bruton's tyrosine kinase (Btk) gene that leads to a severe block in B cell development and a reduced immunoglobulin production in the serum. Btk is particularly responsible for mediating B cell development and maturation through a signaling effect on the B cell receptor BCR. Patients typically present in early childhood with recurrent infections, in particular with extracellular, encapsulated bacteria. XLA is deemed to have a relatively low incidence of disease, with an occurrence rate of approximately 1 in 200,000 live births and a frequency of about 1 in 100,000 male newborns. It has no ethnic predisposition. XLA is treated by infusion of human antibody. Treatment with pooled gamma globulin cannot restore a functional population of B cells, but it is sufficient to reduce the severity and number of infections due to the passive immunity granted by the exogenous antibodies.

<span class="mw-page-title-main">Canine parvovirus</span> Contagious virus mainly affecting dogs

Canine parvovirus is a contagious virus mainly affecting dogs and wolves. CPV is highly contagious and is spread from dog to dog by direct or indirect contact with their feces. Vaccines can prevent this infection, but mortality can reach 91% in untreated cases. Treatment often involves veterinary hospitalization. Canine parvovirus often infects other mammals including foxes, wolves, cats, and skunks. Felines (cats) are also susceptible to panleukopenia, a different strain of parvovirus.

<span class="mw-page-title-main">Vertically transmitted infection</span> Infection caused by pathogens that use mother-to-children transmission

A vertically transmitted infection is an infection caused by pathogenic bacteria or viruses that use mother-to-child transmission, that is, transmission directly from the mother to an embryo, fetus, or baby during pregnancy or childbirth. It can occur when the mother has a pre-existing disease or becomes infected during pregnancy. Nutritional deficiencies may exacerbate the risks of perinatal infections. Vertical transmission is important for the mathematical modelling of infectious diseases, especially for diseases of animals with large litter sizes, as it causes a wave of new infectious individuals.

<span class="mw-page-title-main">Pure red cell aplasia</span> Medical condition

Pure red cell aplasia (PRCA) or erythroblastopenia refers to a type of aplastic anemia affecting the precursors to red blood cells but usually not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells. There are multiple etiologies that can cause PRCA. The condition has been first described by Paul Kaznelson in 1922.

Paroxysmal cold hemoglobinuria (PCH) or Donath–Landsteiner hemolytic anemia (DLHA) is an autoimmune hemolytic anemia featured by complement-mediated intravascular hemolysis after cold exposure. It can present as an acute non-recurrent postinfectious event in children, or chronic relapsing episodes in adults with hematological malignancies or tertiary syphilis. Described by Julius Donath (1870–1950) and Karl Landsteiner (1868–1943) in 1904, PCH is one of the first clinical entities recognized as an autoimmune disorder.

Reticulocytopenia is the medical term for an abnormal decrease in circulating red blood cell precursors (reticulocytes) that can lead to anemia due to resulting low red blood cell (erythrocyte) production. Reticulocytopenia may be an isolated finding or it may not be associated with abnormalities in other hematopoietic cell lineages such as those that produce white blood cells (leukocytes) or platelets (thrombocytes), a decrease in all three of these lineages is referred to as pancytopenia.

<span class="mw-page-title-main">Blueberry muffin baby</span> Medical condition

Blueberry muffin baby, also known as extramedullary hematopoiesis, describes a newborn baby with multiple purpura, associated with several non-cancerous and cancerous conditions in which extra blood is produced in the skin. The bumps range from one to seven mm, do not blanch and have a tendency to occur on the head, neck and trunk. They often fade by three to six weeks after birth, leaving brownish marks. When due to a cancer, the bumps tend to be fewer, firmer and larger.

<span class="mw-page-title-main">Congenital cytomegalovirus infection</span> Medical condition

Congenital cytomegalovirus (cCMV) is cytomegalovirus (CMV) infection in a newborn baby. Most have no symptoms. Some affected babies are small. Other signs and symptoms include a rash, jaundice, hepatomegaly, retinitis, and seizures. It may lead to loss of hearing or vision, developmental disability, or a small head.

An Intrauterine transfusion (IUT) is a procedure that provides blood to a fetus, most commonly through the umbilical cord. It is used in cases of severe fetal anemia, such as when fetal red blood cells are being destroyed by maternal antibodies. IUTs are performed by perinatologists at hospitals or specialized centers.

References

  1. 1 2 3 4 5 Sabella C, Goldfarb J (October 1999). "Parvovirus B19 infections". American Family Physician. 60 (5): 1455–60. PMID   10524489. Archived from the original on 2008-05-14. Retrieved 2009-11-06.
  2. 1 2 3 4 5 6 Servey JT, Reamy BV, Hodge J (February 2007). "Clinical presentations of parvovirus B19 infection". American Family Physician. 75 (3): 373–6. PMID   17304869. Archived from the original on 2008-08-21. Retrieved 2009-11-06.
  3. ↑ "Slapped cheek syndrome". nhs.uk. 2017-10-19. Retrieved 2021-08-31.
  4. ↑ Weir E (March 2005). "Parvovirus B19 infection: fifth disease and more". CMAJ. 172 (6): 743. doi:10.1503/cmaj.045293. PMC   552884 . PMID   15767606.
  5. ↑ "About Human Parvovirus B19 | CDC". www.cdc.gov. 2021-04-01. Retrieved 2021-08-04.
  6. ↑ Feder, Henry M.; Grant-Kels, Jane M. (2008), Schlossberg, David (ed.), "Classic Viral Exanthems", Clinical Infectious Disease, Cambridge: Cambridge University Press, pp. 135–140, doi:10.1017/cbo9780511722240.020, ISBN   978-0-511-72224-0 , retrieved 2022-01-04
  7. 1 2 3 4 "Fifth Disease". MedlinePlus. U.S. National Library of Medicine. Retrieved 2020-10-29.
  8. 1 2 Mankuta D, Bar-Oz B, Koren G (March 1999). "Erythema infectiosum (Fifth disease) and pregnancy". Canadian Family Physician. 45: 603–5. PMC   2328398 . PMID   10099795.
  9. ↑ Yoto Y, Kudoh T, Suzuki N, Matsunaga Y, Chiba S (2003). "Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases". Acta Haematologica. 90 (1): 8–12. doi:10.1159/000204365. PMID   8237278.
  10. 1 2 "Parvovirus B19 | Pregnancy and Fifth Disease | Human Parvovirus B19". U.S. Centers for Disease Control and Prevention (CDC). 2019-11-26. Retrieved 2020-10-29.
  11. 1 2 3 4 Macri A, Crane JS (2021). "Parvoviruses". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   29489222 . Retrieved 2021-07-30.
  12. ↑ Attwood LO, Holmes NE, Hui L (December 2020). "Identification and management of congenital parvovirus B19 infection". Prenatal Diagnosis. 40 (13): 1722–1731. doi:10.1002/pd.5819. hdl: 11343/276375 . PMID   32860469. S2CID   221365636.
  13. 1 2 Manaresi E, Gallinella G (July 2019). "Advances in the Development of Antiviral Strategies against Parvovirus B19". Viruses. 11 (7): 659. doi: 10.3390/v11070659 . PMC   6669595 . PMID   31323869.
  14. 1 2 Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F (2014). "Human parvovirus B19: a review". Acta Virologica. 58 (3): 199–213. doi: 10.4149/av_2014_03_199 . PMID   25283854.
  15. 1 2 Qiu J, Söderlund-Venermo M, Young NS (January 2017). "Human Parvoviruses". Clinical Microbiology Reviews. 30 (1): 43–113. doi:10.1128/CMR.00040-16. PMC   5217800 . PMID   27806994.
  16. ↑ Kerr JR (April 2016). "The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease". Journal of Clinical Pathology. 69 (4): 279–91. doi: 10.1136/jclinpath-2015-203455 . PMID   26644521. S2CID   30319239.
  17. 1 2 Yan J, Xu B (May 2021). "Rare cutaneous manifestations of parvovirus B19 infection in a child". Journal of Paediatrics and Child Health. 57 (5): 749–750. doi:10.1111/jpc.15030. PMID   32722887. S2CID   220850754.
  18. 1 2 Kostolansky S, Waymack JR (2021). "Erythema Infectiosum". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   30020681 . Retrieved 2021-07-27.
  19. ↑ Ornoy A, Ergaz Z (2017). "Parvovirus B19 infection during pregnancy and risks to the fetus". Birth Defects Research. 109 (5): 311–323. doi: 10.1002/bdra.23588 . PMID   28398685.
  20. ↑ Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. (November 2014). "Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis". Pediatrics. 134 (5): e1474-502. doi:10.1007/978-3-030-21267-4_9. PMC   7123921 . PMID   25349312.
  21. ↑ Ramdass P, Mullick S, Farber HF (December 2015). "Viral Skin Diseases". Primary Care. 42 (4): 517–67. doi:10.1016/j.pop.2015.08.006. PMID   26612372.
  22. 1 2 Gryfe, David; Wong, Calvin (April 2019). "Clinical management of an adult with erythema infectiosum: a retrospective case report". The Journal of the Canadian Chiropractic Association. 63 (1): 44–50. ISSN   0008-3194. PMC   6493208 . PMID   31057177.
  23. ↑ Wang, Chia C.; Prather, Kimberly A; Sznitman, Josué; Jimenez, Jose L; Lakdawala, Seema S.; Tufekci, Zeynep; Marr, Linsey C. (27 Aug 2021). "Airborne transmission of respiratory viruses". Science. 373. doi:10.1126/science.abd9149 . Retrieved March 18, 2024.
  24. ↑ Kostolansky, Sean; Waymack, James R. (2021), "Erythema Infectiosum", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   30020681 , retrieved 2021-12-02
  25. ↑ "Parvovirus B19 Infection Medication: Antipyretic agents, Immunologic effectors, Antihistamines". emedicine.medscape.com. Retrieved 2021-12-02.
  26. 1 2 Naides, S J (September 1988). "Erythema infectiosum (fifth disease) occurrence in Iowa". American Journal of Public Health. 78 (9): 1230–1231. doi:10.2105/ajph.78.9.1230. ISSN   0090-0036. PMC   1349405 . PMID   2841879.
  27. ↑ Romero Starke, Karla; Kofahl, Marlen; Freiberg, Alice; Schubert, Melanie; Groß, Mascha Luisa; Schmauder, Stefanie; Hegewald, Janice; Kämpf, Daniel; Stranzinger, Johanna; Nienhaus, Albert; Seidler, Andreas (April 2019). "Are Daycare Workers at a Higher Risk of Parvovirus B19 Infection? A Systematic Review and Meta-Analysis". International Journal of Environmental Research and Public Health. 16 (8): 1392. doi: 10.3390/ijerph16081392 . ISSN   1661-7827. PMC   6517978 . PMID   30999694.
  28. ↑ "Fifth Disease | Winchester Hospital". www.winchesterhospital.org. Retrieved 2021-12-02.
  29. ↑ "Fifth Disease Complications and Prevention". News-Medical.net. 2018-10-16. Retrieved 2021-12-02.
  30. ↑ "Fifth Disease and Pregnancy". American Pregnancy Association. 2014-07-25. Retrieved 2021-12-02.
  31. ↑ Ballou WR, Reed JL, Noble W, Young NS, Koenig S (February 2003). "Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1". The Journal of Infectious Diseases. 187 (4): 675–8. doi: 10.1086/368382 . PMID   12599085.
  32. ↑ Marano, Giuseppe; Vaglio, Stefania; Pupella, Simonetta; Facco, Giuseppina; Calizzani, Gabriele; Candura, Fabio; Liumbruno, Giancarlo M.; Grazzini, Giuliano (April 2015). "Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements". Blood Transfusion. 13 (2): 184–196. doi:10.2450/2014.0174.14. ISSN   1723-2007. PMC   4385066 . PMID   25849894.
  33. 1 2 Morens DM (August 1982). "Fifth disease: Still hazy after all these years". JAMA. 248 (5): 553–4. doi:10.1001/jama.1982.03330050035026. PMID   7097899.
  34. 1 2 Andrade-Filho J (2014). "Analogies in medicine: slapped cheek appearance". Revista do Instituto de Medicina Tropical de Sao Paulo. 56 (5): 458. doi:10.1590/S0036-46652014000500017. PMC   4172122 . PMID   25229231.
  35. ↑ Altman LK (November 30, 1982). "The Doctor's World". The New York Times. Retrieved November 7, 2009.
  36. ↑ Briney RR (November 1965). "Primary cutaneous actinomycosis". JAMA. 194 (6): 679–80. doi:10.1001/jama.1965.03090190101037. PMID   5897250.
  37. ↑ St. Louis Courier of Medicine. Vol. 35. Courier of Medicine Company. 1906.
  38. ↑ Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths P, Schoub B, eds. (2004). "Human Parovirsuses". Principles and Practice of Clinical Virology (5th ed.). Chichester: Wiley. pp. 703–720 (710). ISBN   978-0-470-02096-8.
  39. ↑ Werner GH, Brachman PS, Ketler A, Scully J, Rake G (April 1957). "A new viral agent associated with erythema infectiosum". Annals of the New York Academy of Sciences. 67 (8): 338–45. doi:10.1111/j.1749-6632.1957.tb46058.x. PMID   13411972. S2CID   39593824.
  40. ↑ Starke KR, Kofahl M, Freiberg A, Schubert M, Groß ML, Schmauder S, et al. (2019). "Are Daycare Workers at a Higher Risk of Parvovirus B19 Infection? A Systematic Review and Meta-Analysis". International Journal of Environmental Research and Public Health. 16 (8): 1392. doi: 10.3390/ijerph16081392 . PMC   6517978 . PMID   30999694.
  41. ↑ Radauceanu A, Bouslama M (2020). "Risks for adverse pregnancy outcomes and infections in daycare workers: an overview of current epidemiological evidence and implications for primary prevention". International Journal of Occupational Medicine and Environmental Health. 33 (6): 733–756. doi: 10.13075/ijomeh.1896.01549 . PMID   33029027. S2CID   222214665.
  42. ↑ Obeid Mohamed SO, Osman Mohamed EM, Ahmed Osman AA, Abdellatif MohamedElmugadam FA, Abdalla Ibrahim GA (2019-12-09). "A Meta-Analysis on the Seroprevalence of Parvovirus B19 among Patients with Sickle Cell Disease". BioMed Research International. 2019: 2757450. doi: 10.1155/2019/2757450 . PMC   6925911 . PMID   31886191.
  43. ↑ Soltani S, Zakeri A, Tabibzadeh A, Zandi M, Ershadi E, Akhavan Rezayat S, et al. (2020). "A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients". Tropical Medicine and Health. 48 (1): 96. doi: 10.1186/s41182-020-00284-x . PMC   7709306 . PMID   33292852.
  44. 1 2 3 Bascietto F, Liberati M, Murgano D, Buca D, Iacovelli A, Flacco ME, et al. (November 2018). "Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis". Ultrasound in Obstetrics & Gynecology. 52 (5): 569–576. doi:10.1002/uog.19092. hdl: 11392/2395182 . PMID   29785793. S2CID   29170698.
  45. 1 2 Abbasi N, Johnson JA, Ryan G (August 2017). "Fetal anemia". Ultrasound in Obstetrics & Gynecology. 50 (2): 145–153. doi: 10.1002/uog.17555 . PMID   28782230.
  46. ↑ Xiong YQ, Tan J, Liu YM, He Q, Li L, Zou K, Sun X (May 2019). "The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis". Journal of Clinical Virology. 114: 12–20. doi:10.1016/j.jcv.2019.03.004. PMID   30897374. S2CID   85445732.
  47. ↑ Barah F, Whiteside S, Batista S, Morris J (May 2014). "Neurological aspects of human parvovirus B19 infection: a systematic review". Reviews in Medical Virology. 24 (3): 154–68. doi:10.1002/rmv.1782. PMC   4238837 . PMID   24459081.
  48. ↑ Tschöpe C, Ammirati E, Bozkurt B, Caforio AL, Cooper LT, Felix SB, et al. (March 2021). "Myocarditis and inflammatory cardiomyopathy: current evidence and future directions". Nature Reviews. Cardiology. 18 (3): 169–193. doi:10.1038/s41569-020-00435-x. PMC   7548534 . PMID   33046850.
  49. ↑ Koduri PR (January 2000). "Parvovirus B19-related anemia in HIV-infected patients". AIDS Patient Care and STDs. 14 (1): 7–11. doi:10.1089/108729100318082. PMID   12240888.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.